This announcement is a separate document:
北京市君致律师事务所关于新华医疗回购注销2021年限制性股票激励计划部分限制性股票及调整回购价格之法律意见书
Legal opinion of Junzhi Law Firm, Peking Municipality, regarding the repurchase cancellation of part of the restricted stocks and adjustment of the repurchase price in Shinva Medical Instrument's 2021 restricted stock incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.